A number of research groups have recently demonstrated the role of the human gut microbiota in metabolism and metabolic disease, leading to the attempt to develop microbial therapeutics
It has been postulated that the increase in allergic diseases may be due to bacterial dysbiosis and reduced biodiversity of the healthy microbiota [1, 2, 39]
According to the National Institutes of Health (NIH) and Mayo Clinic, GLP-1 receptor agonists help by: Increasing insulin release when blood sugar is high Reducing glucagon, which lowers excess blood sugar Slowing stomach emptying Reducing appetite and increasing feelings of fullness These effects make GLP-1 medicines useful for: Type 2 diabetes Obesity and weight management Reducing cardiovascular risk in people with diabetes Injectable GLP-1 Medicines Most GLP-1 medicines currently in use are injectable, taken either daily or weekly
FDA-Approved GLP-1s The FDA has approved certain GLP-1s for weight loss use and others specifically for treatment of diabetes: Key Considerations for Plan Sponsors Alternative non-GLP-1 options : Scriptas Med Mapper identifies highly effective non-GLP-1 weight loss medications that may offer lower-cost alternatives, have different side effects, and are easier to find
As industry leaders in the ophthalmic market, we deliver the life-changing products and solutions that enable them to make a difference
If you want clear medical oversight, Calibrate stands out
